The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis
Authors:
- Marie WunschMWMarie Wunsch
- Christopher HohmannCHChristopher Hohmann
- Bianca MillesBMBianca Milles
- Christina RostermundCRChristina Rostermund
- Paul V. LehmannPaul V. Lehmann
- Michael SchroeterMSMichael Schroeter
- Antonios BayasABAntonios Bayas
- Jochen UlzheimerJUJochen Ulzheimer
- Mathias MäurerMMMathias Mäurer
- Süleyman ErgünSüleyman Ergün
- Stefanie KuertenSKStefanie Kuerten
Open Access
Abstract
There is a largely divergent body of literature regarding the relationship between Epstein-Barr virus (EBV) infection and brain inflammation in multiple sclerosis (MS). Here, we tested MS patients during relapse (n = 11) and in remission (n = 19) in addition to n = 22 healthy controls to study the correlation between the EBV- and brain-specific B cell response in the blood by enzyme-linked immunospot (ELISPOT) and enzyme-linked immunosorbent assay (ELISA). Cytomegalovirus (CMV) was used as a control antigen tested in n = 16 MS patients during relapse and in n = 35 patients in remission. Over the course of the study, n = 16 patients were untreated, while n = 33 patients received immunomodulatory therapy. The data show that there was a moderate correlation between the frequencies of EBV- and brain-reactive B cells in MS patients in remission. In addition we could detect a correlation between the B cell response to EBV and disease activity. There was no evidence of an EBV reactivation. Interestingly, there was also a correlation between the frequencies of CMV- and brain-specific B cells in MS patients experiencing an acute relapse and an elevated B cell response to CMV was associated with higher disease activity. The trend remained when excluding seronegative subjects but was non-significant. These data underline that viral infections might impact the immunopathology of MS, but the exact link between the two entities remains subject of controversy.Keywords
This publication has 38 references indexed in Scilit:
- Risk factors for multiple sclerosis and associations with anti-EBV antibody titersClinical Immunology, 2015
- Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodiesJournal of Neuroinflammation, 2014
- Regulation of Epstein–Barr virus reactivation from latencyMicrobiology and Immunology, 2014
- Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple SclerosisPLOS ONE, 2014
- Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University StudentsThe Journal of Infectious Diseases, 2012
- Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnelMultiple Sclerosis Journal, 2011
- Epstein–Barr Virus Infection and Multiple Sclerosis: A ReviewJournal of Neuroimmune Pharmacology, 2010
- Dysregulated Epstein-Barr virus infection in the multiple sclerosis brainJournal of Experimental Medicine, 2007
- Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysisAnnals of Neurology, 2006
- Epstein-Barr virus and disease activity in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2005